The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...

Dr. Athalye’s previous leadership roles span Biocon Biologics, Boehringer Ingelheim, Novartis, and Schering-Plough Research ...

Newly Appointed Kashiv BioSciences CEO, Dr. Sandeep Nilkanth Athalye (Photo: Business Wire) ...

A new survey shows that three Big Pharmas have stolen the hearts of patient groups representing nearly 1 million people with cardiovascular conditions. | A new survey shows that three Big Pharmas have ...

Indigo Ag has hired a new chief financial officer, while a biotech developing a potential epilepsy drug got a Series A as ...

After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer last year for a whopping $43 billion, former CEO David Epstein ...

David Epstein has joined Ottimo Pharma, which is developing an antibody drug that board member and longtime Roche dealmaker ...

aus 29 Bewertungen Der Herr Eschborn ist als Anwalt sehr Kompetent, Vertrauenswürdig ,freundlich im Kontakt, hat mir sehr bei meiner … (22.10.2024) ...

Ingelheim (ots) - Am 26.10.2024 kam es gegen 14:50 Uhr zu einem Diebstahl in der Goldschmiede Zwehn in der Binger Straße in Ingelheim am Rhein. Hierbei erbeutete der männliche Täter mehrere ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...

Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...